The CVProfilor® DO-2020: An easy-to-use,
non-invasive System designed to provide physicians in the
U.S. with a means for assessing a patient’s vascular health.
The CVProfilor® utilizes HD’s patented,
proprietary and validated blood pressure waveform
technology. The System is non-invasive, user-friendly,
designed for use in U.S. physician offices and clinics, and
involves no specific medical risk to the patient.
The System’s display screen and
printer-generated CardioVascular Profile Report provide an
independent assessment of the patient’s arterial elasticity
or flexibility of both large and small arteries (referred to
as C1 and C2 parameters, respectively).
The CVProfilor® DO-2020 provides a patient’s
arterial elasticity indices which can be used in the
assessment for underlying vascular disease.
Employing prototype Systems of the
CVProfilor® DO-2020, clinical investigators have
demonstrated an age-related loss of elasticity of both the
large and small arteries as well as a correlation between
hardening of the arteries and vascular disease. This
clinical research, conducted during the last decade and
described in more than 300 scientific abstracts and articles
published in peer-reviewed medical journals, suggests that
"premature stiffening" of a patient’s arteries is a
clinically sensitive marker for the early onset of
Clinical studies have shown that patients
with hypertension, heart failure, coronary artery disease
and diabetes exhibit a loss of arterial elasticity. Even a
slight reduction in C2 or small arterial elasticity can be
measured by the CVProfilor® DO-2020 System, and the early
such reductions appear to precede the overt signs and
symptoms of cardiovascular disease.
It is generally recognized by medical
experts that healthy arteries are elastic and flexible, and
that hardening or stiffening of arteries is associated with
old age, poor health and cardiovascular disease.
Cardiovascular disease is the leading cause of death
worldwide. The American Heart Association estimates that
more than 74 million American adults have high blood
pressure and that 34% of all deaths in the United States (as
of 2006) can attribute cardiovascular disease as the
underlying cause of death. Cardiovascular disease is the
primary cause of more than one and a half million heart
attacks and strokes annually. Every 24 hours, more than
2,300 Americans die of disease involving the cardiovascular
system – an average of one death every 38 seconds!
The CVProfilor® DO-2020 System is
manufactured to ISO 13485 standards and is FDA approved